Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2012        Go!    
March 29, Sunday 2015 9:49 PM       

       HEADLINES: Keralites stranded in Yemen seek help                                              Confident of getting GST opposing states on board: Mani                                              Rajnath moves to new bungalow; neighbours include LS Speaker                                              India deeply valued Lee's friendship and his support: Modi                                              Blackmoney: Swiss banks seek fresh undertakings from Indians                                              Michelle Obama declares 'Black Girls Rock!'                                              Eiffel Tower goes dark in symbolic move for Earth Hour                                              Boko Haram kills 41, prevents hundreds voting in Nigeria                                              Clarke to bid adieu from ODI cricket after World Cup final                                              Gutsy NZ ready for mighty Australia in WC summit clash                                              Sure Indians will be rooting for New Zealand: McCullum                                              Kaumudi Facebook
       BUSINESS Next Article: SBI mulls selling bad assets to ARCs in Jan-Mar quarter  
       Ranbaxy recalls over 64,000 bottles of generic Lipitor in US
         Posted on :22:10:56 Mar 8, 2014
       Last edited on:22:10:56 Mar 8, 2014
         Tags: Ranbaxy, Lipitor in US

NEW DELHI: Drug major Ranbaxy Laboratories has recalled over 64,000 bottles of Atorvastatin calcium tablets, a generic version of cholesterol-lowering drug Lipitor, after a complaint of wrong dosage.

The Indian firm, which is reeling under regulatory action from the US Food and Drug Administration (USFDA), recalled the drug after a complaint by a pharmacist who discovered a 20 mg tablet inside a sealed bottle of Atorvastatin 10 mg tablets.

"Ranbaxy Pharmaceuticals is conducting a voluntary recall in the US limited to two lots of Atorvastatin calcium tablets, 10 mg manufactured in India which expire in May 2014," it said in a statement.

The company, majority owned by Japan's Daiichi Sankyo, said it recalled the tablets "because of a remote possibility of the presence of a 20 mg Atorvastatin calcium tablet in a 10 mg bottle."

"This is the basis of the voluntary recall," it added.

To date, Ranbaxy has not received any product complaints related to these batches, the company said.

"Other lot numbers, package sizes and strengths are not affected by this recall. The recall is being conducted at the retail level," it added.

Ranbaxy is withdrawing the lots out of abundant caution, keeping the safety of patients in mind and with full knowledge of the USFDA, it said.

In January, the USFDA prohibited Ranbaxy from producing and distributing drugs for the American market from its Toansa facility in Punjab.

The Toansa plant catered to over 70 per cent of Ranbaxy's requirement for raw material used in medicine formulations. Toansa was the fourth Ranbaxy plant banned by the USFDA.

In September, the USFDA imposed an import alert on Ranbaxy's Mohali plant in Punjab for violating good manufacturing norms.

Ranbaxy's key facilities at Paonta Sahib in Himachal Pradesh and Dewas in Madhya Pradesh have been under a US import alert since 2008.

Next Article: SBI mulls selling bad assets to ARCs in Jan-Mar quarter
Industrial oils recover on mild demand  
TRAI seeks views to regulate net-based calling, messaging apps  
Honda Motorcycle to expand Karnataka plant  
Vistara launches special fares starting at Rs 2,129  
Ford looks to triple exports from India in 5 years  
Tata JLR announces mega 600mn pound investment in UK  
Sensex falls to 10-week low on foreign outflow concerns  
Listed companies to disclose specific details on frauds  
Sun Pharma to delist Ranbaxy on completion of $4 bn merger  
Sensex up 65 points; healthcare stocks gain  
India to grow at 7.8% in 2015-16; surpass China: ADB  
Nokia may be allowed to sell Chennai mobile plant  
Russia may import Indian dairy products soon  
India needs to become competitive in infra, tax policy: FM  
Sebi ups crackdown; busts illicit fund-raising of Rs 13,000 cr  
Sensex jumps 350 points in early trade on global cues  
'India's digital commerce mkt to surpass Rs 1 lakh cr by 2015'  
Sensex rises 70 points in early trade  
Natural gas price to be cut by 10% to USD 5.02/unit from Apr 1  
Xiaomi India's top 4G handset vendor in Jan;pips Samsung,Apple  
Sensex up 203 pts in early trade on positive global cues  
Oil prices mixed in Asia, US crude near six-year lows  
India bright spot in global economy,will clock 7.2% growth:IMF  
Inflation falls to (-)2.06% in Feb on cheaper food, fuel items  
Wipro hires ex-TCS executive as COO  
Is AAP heading for a split?
Don't Know
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy